TENNOR THERAPEUTICS
TenNor Therapeutics is a clinical stage global biopharmaceutical company dedicated to development of differentiated products for the treatment of rare diseases associated with bacterial infections. TenNor possesses a strong new drug development portfolio, targeting medical device associated bacterial biofilm infections, cirrhosis hepatic encephalopathy and Helicobacter pylori infection, to address unmet medical needs in these areas.
Last updated on